WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Dr. Aarati Patil, Dr. Kirti Singh, *Dr. Kshitija Berde, Dr. Aishwarya Deshpande

ABSTRACT

Low Anti-Müllerian Hormone (AMH) levels—typically below 1 ng/mL—indicate a severely diminished ovarian reserve and are considered a strong predictor of poor response to conventional fertility treatments. In such cases, the likelihood of natural conception is often deemed negligible, and donor egg IVF is commonly advised. This case study presents the Ayurvedic management of a 39-year-old woman with a critically low AMH level of 0.06 ng/mL, a five-year history of secondary infertility, and an intramural uterine fibroid. The patient was treated with a personalized Ayurvedic regimen comprising of the proprietary medicines- Poshini, Bhedini, Vardhani, and Upaja—formulations aimed at improving egg quality, enhancing follicular response and ovulation, clearing srotorodha (channel obstruction), and restoring hormonal and uterine balance. By the third month, ovulation was documented despite negligible AMH, and spontaneous conception occurred in the sixth month. This case highlights the potential of individualized Ayurvedic treatment in modulating the internal environment to optimize ovarian function and support conception, even in cases of profoundly low AMH. These findings call for further mechanistic studies and larger clinical evaluations to explore the role of Ayurveda as a complementary strategy in fertility care.